Mereo BioPharma Group plc
MREO
$2.33
$0.031.30%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -43.25M | -45.32M | -36.85M | -26.34M | -29.47M |
| Total Depreciation and Amortization | 1.09M | 1.10M | 1.10M | 1.11M | 1.06M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.70M | 17.35M | 8.51M | 8.83M | 8.87M |
| Change in Net Operating Assets | -369.00K | -3.33M | 7.22M | -3.47M | -1.59M |
| Cash from Operations | -32.83M | -30.20M | -20.03M | -19.88M | -21.13M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -699.00K | -699.00K | -699.00K | -700.00K | -419.00K |
| Cash from Investing | -699.00K | -699.00K | -699.00K | -700.00K | -419.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | -3.19M | -3.19M | -3.19M |
| Issuance of Common Stock | 47.00M | 47.00M | 58.61M | 11.61M | 11.61M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -853.00K | -813.00K | -730.00K | -444.00K | -444.00K |
| Cash from Financing | 46.15M | 46.19M | 54.69M | 7.97M | 7.97M |
| Foreign Exchange rate Adjustments | -233.00K | 2.71M | 502.00K | 1.46M | 2.82M |
| Miscellaneous Cash Flow Adjustments | -- | -1.00K | -1.00K | -1.00K | -1.00K |
| Net Change in Cash | 12.38M | 17.99M | 34.46M | -11.15M | -10.76M |